skip to main content

S. 3380: A bill to direct the Office of National Drug Control Policy to track and review federally funded drug demand reduction activities.

Call or Write Congress

Sponsor and status

Joe Donnelly

Sponsor. Senior Senator for Indiana. Democrat.

Read Text »
Last Updated: Aug 23, 2018
Length: 3 pages
Introduced:

Aug 23, 2018

Status:

Introduced on Aug 23, 2018

This bill is in the first stage of the legislative process. It was introduced into Congress on August 23, 2018. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.

Prognosis:

2% chance of being enacted according to Skopos Labs (details)

History

Aug 23, 2018
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

If this bill has further action, the following steps may occur next:
 
Passed Committee

 
Passed Senate

 
Passed House

 
Signed by the President

S. 3380 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 3380 — 115th Congress: A bill to direct the Office of National Drug Control Policy to track and review ...” www.GovTrack.us. 2018. September 25, 2018 <https://www.govtrack.us/congress/bills/115/s3380>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.